LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection.

    Sabers, Andrew J / Williams, Amber L / Farley, T Michael

    BMJ case reports

    2020  Volume 13, Issue 10

    Abstract: An 82-year-old man with an extensive medical history presented to the emergency room with complaints of generalised weakness and cough. He tested positive for COVID-19 10 days prior to presenting to the emergency room. Although his symptoms started a ... ...

    Abstract An 82-year-old man with an extensive medical history presented to the emergency room with complaints of generalised weakness and cough. He tested positive for COVID-19 10 days prior to presenting to the emergency room. Although his symptoms started a week prior to diagnosis, his weakness increased, warranting emergency response. A comprehensive metabolic panel was drawn from the patient on admission, indicating markedly high liver function tests (LFTs) ≥20 times above the upper limit of normal. On day 1 of admission, the decision was still made to start remdesivir (5-day course) due to decompensated acute respiratory failure as well as dexamethasone. The patient's LFTs significantly improved throughout his hospital stay. The patient made a full recovery and was discharged on day 10 of hospitalisation.
    MeSH term(s) Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/analogs & derivatives ; Aged, 80 and over ; Alanine/administration & dosage ; Alanine/analogs & derivatives ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/drug therapy ; Dexamethasone/administration & dosage ; Emergency Service, Hospital ; Humans ; Length of Stay ; Liver Diseases/complications ; Liver Diseases/diagnosis ; Liver Function Tests ; Male ; Pandemics/prevention & control ; Pandemics/statistics & numerical data ; Patient Discharge ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/drug therapy ; Respiratory Insufficiency/diagnosis ; Respiratory Insufficiency/therapy ; Severity of Illness Index ; Treatment Outcome ; COVID-19 Drug Treatment
    Chemical Substances remdesivir (3QKI37EEHE) ; Adenosine Monophosphate (415SHH325A) ; Dexamethasone (7S5I7G3JQL) ; Alanine (OF5P57N2ZX)
    Keywords covid19
    Language English
    Publishing date 2020-10-31
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ISSN 1757-790X
    ISSN (online) 1757-790X
    DOI 10.1136/bcr-2020-239210
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection

    Sabers, Andrew J / Williams, Amber L / Farley, T Michael

    BMJ case reports

    Abstract: An 82-year-old man with an extensive medical history presented to the emergency room with complaints of generalised weakness and cough. He tested positive for COVID-19 10 days prior to presenting to the emergency room. Although his symptoms started a ... ...

    Abstract An 82-year-old man with an extensive medical history presented to the emergency room with complaints of generalised weakness and cough. He tested positive for COVID-19 10 days prior to presenting to the emergency room. Although his symptoms started a week prior to diagnosis, his weakness increased, warranting emergency response. A comprehensive metabolic panel was drawn from the patient on admission, indicating markedly high liver function tests (LFTs) ≥20 times above the upper limit of normal. On day 1 of admission, the decision was still made to start remdesivir (5-day course) due to decompensated acute respiratory failure as well as dexamethasone. The patient's LFTs significantly improved throughout his hospital stay. The patient made a full recovery and was discharged on day 10 of hospitalisation.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #901292
    Database COVID19

    Kategorien

  3. Article ; Online: Use of remdesivir in the presence of elevated LFTs for the treatment of severe COVID-19 infection

    Sabers, Andrew J / Williams, Amber L / Farley, T Michael

    BMJ Case Reports

    2020  Volume 13, Issue 10, Page(s) e239210

    Abstract: An 82-year-old man with an extensive medical history presented to the emergency room with complaints of generalised weakness and cough. He tested positive for COVID-19 10 days prior to presenting to the emergency room. Although his symptoms started a ... ...

    Abstract An 82-year-old man with an extensive medical history presented to the emergency room with complaints of generalised weakness and cough. He tested positive for COVID-19 10 days prior to presenting to the emergency room. Although his symptoms started a week prior to diagnosis, his weakness increased, warranting emergency response. A comprehensive metabolic panel was drawn from the patient on admission, indicating markedly high liver function tests (LFTs) ≥20 times above the upper limit of normal. On day 1 of admission, the decision was still made to start remdesivir (5-day course) due to decompensated acute respiratory failure as well as dexamethasone. The patient’s LFTs significantly improved throughout his hospital stay. The patient made a full recovery and was discharged on day 10 of hospitalisation.
    Keywords covid19
    Language English
    Publisher BMJ
    Publishing country uk
    Document type Article ; Online
    ISSN 1757-790X
    DOI 10.1136/bcr-2020-239210
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top